Alarm as medication taken by thousands of Brits is linked to dementia in new research

Common Bladder Medication May Increase Dementia Risk, Study Finds

Certain widely prescribed medications for overactive bladders may be linked to an increased chance of developing dementia, a new study suggests.

Concerns Over Common Treatment

The study, involving nearly 1 million people, found that some types of anticholinergic drugs were associated with an 18% increased risk of dementia diagnoses. It highlights a growing concern surrounding the safety and long-term effects of this common treatment method.

Those prescribed oxybutynin hydrochloride, sold under brands like Aspire, Ditropan, and Kentera, exhibited a 31% higher risk, while individuals taking tolterodine tartrate had a 27% increased risk. Researchers emphasized that not all anticholinergics carry

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

IndyCar team owners get first look at proposed 2027 design

Sunny Deol recalls big production houses hesitating to work with him, Dharmendra: ‘hum log darte nahin’ | Bollywood

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.